المؤلفون: Fisher R; Faculty of Life Sciences and Medicine, Hodgkin Building, King's College London, Guy's Campus, London, SE1 1UL, UK., Hikima A; Faculty of Life Sciences and Medicine, Hodgkin Building, King's College London, Guy's Campus, London, SE1 1UL, UK., Morris R; Faculty of Life Sciences and Medicine, Hodgkin Building, King's College London, Guy's Campus, London, SE1 1UL, UK., Jackson MJ; Faculty of Life Sciences and Medicine, Hodgkin Building, King's College London, Guy's Campus, London, SE1 1UL, UK., Rose S; Faculty of Life Sciences and Medicine, Hodgkin Building, King's College London, Guy's Campus, London, SE1 1UL, UK., Varney MA; Neurolixis SAS, 2 Rue Georges Charpak, 81100, Castres, France., Depoortere R; Neurolixis SAS, 2 Rue Georges Charpak, 81100, Castres, France., Newman-Tancredi A; Neurolixis SAS, 2 Rue Georges Charpak, 81100, Castres, France. Electronic address: anewmantancredi@neurolixis.com.

المصدر: Neuropharmacology [Neuropharmacology] 2020 May 01; Vol. 167, pp. 107997. Date of Electronic Publication: 2020 Feb 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Dyskinesia Agents/*therapeutic use , Antiparkinson Agents/*therapeutic use , Dyskinesia, Drug-Induced/*drug therapy , MPTP Poisoning/*drug therapy , Piperidines/*therapeutic use , Pyridines/*therapeutic use , Serotonin 5-HT1 Receptor Agonists/*therapeutic use, Animals ; Anti-Dyskinesia Agents/pharmacology ; Antiparkinson Agents/pharmacology ; Callithrix ; Dyskinesia, Drug-Induced/metabolism ; Dyskinesia, Drug-Induced/physiopathology ; Female ; Levodopa/toxicity ; Locomotion/drug effects ; Locomotion/physiology ; MPTP Poisoning/metabolism ; MPTP Poisoning/physiopathology ; Male ; Piperidines/pharmacology ; Pyridines/pharmacology ; Receptor, Serotonin, 5-HT1A/metabolism ; Serotonin 5-HT1 Receptor Agonists/pharmacology ; Treatment Outcome

المؤلفون: Fernandez HH; Center for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio, USA fernanh@ccf.org., Stamler D; Former employee of Teva Pharmaceuticals, La Jolla, California, USA., Davis MD; Teva Pharmaceuticals, Frazer, Pennsylvania, USA., Factor SA; Jean and Paul Amos Parkinson's Disease and Movement Disorder Program, Emory University School of Medicine, Atlanta, Georgia, USA., Hauser RA; University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa, Florida, USA., Jimenez-Shahed J; Baylor College of Medicine, Houston, Texas, USA., Ondo WG; Methodist Neurological Institute, Houston, Texas, USA.; Weill Cornell Medical College, New York, New York, USA., Jarskog LF; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Woods SW; Yale University School of Medicine, New Haven, Connecticut, USA., Bega D; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., LeDoux MS; University of Tennessee Health Science Center, Memphis, Tennessee, USA., Shprecher DR; University of Utah, Salt Lake City, Utah, USA.; Banner Sun Health Research Institute, Sun City, Arizona, USA., Anderson KE; Georgetown University, Washington, District of Columbia, USA.

المصدر: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2019 Dec; Vol. 90 (12), pp. 1317-1323. Date of Electronic Publication: 2019 Jul 10.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-330X (Electronic) Linking ISSN: 00223050 NLM ISO Abbreviation: J Neurol Neurosurg Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Dyskinesia Agents/*therapeutic use , Tardive Dyskinesia/*drug therapy , Tetrabenazine/*analogs & derivatives, Adult ; Aged ; Anti-Dyskinesia Agents/adverse effects ; Antipsychotic Agents/adverse effects ; Cytochrome P-450 CYP2D6 Inhibitors/adverse effects ; Cytochrome P-450 CYP2D6 Inhibitors/therapeutic use ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Mood Disorders/complications ; Mood Disorders/drug therapy ; Psychotic Disorders/complications ; Psychotic Disorders/drug therapy ; Tardive Dyskinesia/physiopathology ; Tetrabenazine/adverse effects ; Tetrabenazine/therapeutic use ; Treatment Outcome

المؤلفون: Cofré Lizama LE; Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Australia; Australian Rehabilitation Research Centre (ARRC), Royal Melbourne Hospital, Australia. Electronic address: eduardo.cofre@unimelb.edu.au., Khan F; Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Australia; Australian Rehabilitation Research Centre (ARRC), Royal Melbourne Hospital, Australia; Department of Rehabiliation Medicine, Royal Melbourne Hospital, Australia., Galea MP; Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Australia; Australian Rehabilitation Research Centre (ARRC), Royal Melbourne Hospital, Australia; Department of Rehabiliation Medicine, Royal Melbourne Hospital, Australia.

المصدر: Gait & posture [Gait Posture] 2019 May; Vol. 70, pp. 389-396. Date of Electronic Publication: 2019 Apr 04.

نوع المنشور: Journal Article; Systematic Review

بيانات الدورية: Publisher: Elsevier Sciencem Country of Publication: England NLM ID: 9416830 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2219 (Electronic) Linking ISSN: 09666362 NLM ISO Abbreviation: Gait Posture Subsets: MEDLINE

مواضيع طبية MeSH: Stroke* , Walking Speed*, Anti-Dyskinesia Agents/*therapeutic use , Botulinum Toxins, Type A/*therapeutic use , Gait/*drug effects , Gait Disorders, Neurologic/*drug therapy, Anti-Dyskinesia Agents/administration & dosage ; Anti-Dyskinesia Agents/pharmacology ; Botulinum Toxins, Type A/administration & dosage ; Botulinum Toxins, Type A/pharmacology ; Humans ; Injections, Intramuscular

المؤلفون: Huot P; Neurodegenerative Disease Group, Montreal Neurological Institute, Montreal, QC, H3A 2B4, Canada.; Department of Neurology & Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.; Division of Neurology, McGill University Health Centre, Montreal, QC, H3A 2B4, Canada.

المصدر: Neurodegenerative disease management [Neurodegener Dis Manag] 2018 Aug; Vol. 8 (4), pp. 207-209. Date of Electronic Publication: 2018 Jul 24.

نوع المنشور: Editorial; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Future Medicine Country of Publication: England NLM ID: 101517977 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-2032 (Electronic) Linking ISSN: 17582024 NLM ISO Abbreviation: Neurodegener Dis Manag Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Dyskinesia Agents/*pharmacology , Anti-Dyskinesia Agents/*therapeutic use , Dyskinesia, Drug-Induced/*drug therapy , Parkinsonian Disorders/*drug therapy , Serotonin 5-HT1 Receptor Agonists/*pharmacology, Animals ; Anti-Dyskinesia Agents/adverse effects ; Dyskinesia, Drug-Induced/metabolism ; Humans ; Parkinsonian Disorders/metabolism ; Serotonin/metabolism ; Serotonin 5-HT1 Receptor Agonists/therapeutic use

المؤلفون: Zanforlin E; Department of Pharmaceutical and Pharmacological Sciences, University of Padova , Padova 35131, Italy., Zagotto G; Department of Pharmaceutical and Pharmacological Sciences, University of Padova , Padova 35131, Italy., Ribaudo G; Department of Pharmaceutical and Pharmacological Sciences, University of Padova , Padova 35131, Italy.

المصدر: ACS chemical neuroscience [ACS Chem Neurosci] 2017 Nov 15; Vol. 8 (11), pp. 2356-2368. Date of Electronic Publication: 2017 Sep 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101525337 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1948-7193 (Electronic) Linking ISSN: 19487193 NLM ISO Abbreviation: ACS Chem Neurosci Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Dyskinesia Agents/*chemistry , Biological Products/*chemistry , Huntington Disease/*drug therapy , Parkinson Disease/*drug therapy, Animals ; Anti-Dyskinesia Agents/chemical synthesis ; Anti-Dyskinesia Agents/economics ; Anti-Dyskinesia Agents/therapeutic use ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Antiparkinson Agents/chemical synthesis ; Antiparkinson Agents/chemistry ; Antiparkinson Agents/economics ; Antiparkinson Agents/therapeutic use ; Autophagy/drug effects ; Biological Products/economics ; Biological Products/therapeutic use ; Dementia/drug therapy ; Dementia/economics ; Dementia/epidemiology ; Dopamine/metabolism ; Drug Discovery ; Drug Evaluation, Preclinical ; Humans ; Huntington Disease/economics ; Huntington Disease/epidemiology ; Huntington Disease/physiopathology ; Microglia/drug effects ; Mitochondria/drug effects ; Molecular Targeted Therapy ; Monoamine Oxidase Inhibitors/therapeutic use ; Oxidative Stress/drug effects ; Parkinson Disease/economics ; Parkinson Disease/epidemiology ; Parkinson Disease/physiopathology ; Plant Preparations/pharmacology ; Plant Preparations/therapeutic use ; Protein Aggregation, Pathological/drug therapy ; Signal Transduction/drug effects ; alpha-Synuclein/antagonists & inhibitors

المؤلفون: Kamate M; Department of Pediatrics, KLE University's J N Medical College, Belgaum, Karnataka State, India. Electronic address: drmaheshkamate@gmail.com., Mittal N; Department of Pediatrics, KLE University's J N Medical College, Belgaum, Karntaka State, India., Metgud D; Department of Pediatric Physiotherapy, KLE College of Physiotherapy, Department of Pediatrics and Pediatric Physiotherapy, KLE University's J N Medical College, Belgaum, Karnataka State, India.

المصدر: Pediatric neurology [Pediatr Neurol] 2018 Jul; Vol. 84, pp. 46-48. Date of Electronic Publication: 2018 Apr 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 8508183 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5150 (Electronic) Linking ISSN: 08878994 NLM ISO Abbreviation: Pediatr Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Outcome Assessment, Health Care* , Quality of Life*, Anti-Dyskinesia Agents/*pharmacology , Cerebral Palsy/*drug therapy , Dyskinesias/*drug therapy , Risperidone/*pharmacology, Anti-Dyskinesia Agents/administration & dosage ; Cerebral Palsy/complications ; Child ; Child, Preschool ; Chorea/drug therapy ; Chorea/etiology ; Dyskinesias/etiology ; Female ; Humans ; Male ; Risperidone/administration & dosage ; Severity of Illness Index ; Upper Extremity/physiopathology

المؤلفون: Lin CC; Methodist Neurological Institute, Houston, TX, USA., Ondo WG; Methodist Neurological Institute, Houston, TX, USA; Weill Cornell Medical School, New York, NY, USA. Electronic address: wondo@houstonmethodist.org.

المصدر: Journal of the neurological sciences [J Neurol Sci] 2018 Jun 15; Vol. 389, pp. 48-54. Date of Electronic Publication: 2018 Feb 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5883 (Electronic) Linking ISSN: 0022510X NLM ISO Abbreviation: J Neurol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Electroconvulsive Therapy*, Anti-Dyskinesia Agents/*therapeutic use , Tardive Dyskinesia/*therapy, Animals ; Anti-Dyskinesia Agents/pharmacology ; Clinical Trials as Topic ; Humans

المؤلفون: Sonego AB; Department of Pharmacology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14049-900, Brazil. Electronic address: andreza_buzolin@hotmail.com., Prado DDS; Department of Pharmacology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14049-900, Brazil., Guimarães FS; Department of Pharmacology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14049-900, Brazil.

المصدر: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2021 Dec 20; Vol. 111, pp. 110367. Date of Electronic Publication: 2021 May 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 8211617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4216 (Electronic) Linking ISSN: 02785846 NLM ISO Abbreviation: Prog Neuropsychopharmacol Biol Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Cognitive Dysfunction*/drug therapy , Cognitive Dysfunction*/prevention & control, Antipsychotic Agents/*adverse effects , Cannabidiol/*pharmacology , Dyskinesias/*drug therapy , PPAR gamma/*therapeutic use , Tardive Dyskinesia/*chemically induced, Animals ; Anti-Dyskinesia Agents/adverse effects ; Anti-Dyskinesia Agents/pharmacology ; Behavior, Animal/drug effects ; Cannabidiol/administration & dosage ; Corpus Striatum/drug effects ; Haloperidol/adverse effects ; Haloperidol/pharmacology ; Male ; Mastication/drug effects ; Mice ; Neostriatum/drug effects ; Rats ; Rats, Wistar

المؤلفون: McEntire MS, Sanchez CR

المصدر: Journal of avian medicine and surgery [J Avian Med Surg] 2017 Sep; Vol. 31 (3), pp. 232-238.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Association of Avian Veterinarians Country of Publication: United States NLM ID: 9512497 Publication Model: Print Cited Medium: Print ISSN: 1082-6742 (Print) Linking ISSN: 10826742 NLM ISO Abbreviation: J Avian Med Surg Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Dyskinesia Agents/*therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use , Bird Diseases/*etiology , Fluid Therapy/*veterinary , Muscle Relaxants, Central/*therapeutic use , Muscular Diseases/*veterinary, Animals ; Animals, Zoo ; Anti-Dyskinesia Agents/administration & dosage ; Anti-Infective Agents/administration & dosage ; Anti-Infective Agents/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Bird Diseases/therapy ; Birds ; Haloperidol/administration & dosage ; Haloperidol/therapeutic use ; Male ; Meloxicam/administration & dosage ; Meloxicam/therapeutic use ; Methocarbamol/administration & dosage ; Methocarbamol/therapeutic use ; Muscle Relaxants, Central/administration & dosage ; Muscular Diseases/etiology ; Muscular Diseases/therapy ; Physical Conditioning, Animal ; Rehabilitation

المؤلفون: Maas RPPWM; From the Department of Neurology (R.P.P.W.M.M., T.W., B.P.C.v.d.W.), Donders Institute for Brain, Cognition, and Behaviour (R.P.P.W.M.M., T.W., B.P.C.v.d.W., M.A.A.P.W.), and Department of Pediatric Neurology (M.A.A.P.W.), Radboud University Medical Center, Nijmegen, the Netherlands; and Complex Motor Disorders Service (J.-P.L.), Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. roderick.maas@radboudumc.nl., Wassenberg T; From the Department of Neurology (R.P.P.W.M.M., T.W., B.P.C.v.d.W.), Donders Institute for Brain, Cognition, and Behaviour (R.P.P.W.M.M., T.W., B.P.C.v.d.W., M.A.A.P.W.), and Department of Pediatric Neurology (M.A.A.P.W.), Radboud University Medical Center, Nijmegen, the Netherlands; and Complex Motor Disorders Service (J.-P.L.), Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Lin JP; From the Department of Neurology (R.P.P.W.M.M., T.W., B.P.C.v.d.W.), Donders Institute for Brain, Cognition, and Behaviour (R.P.P.W.M.M., T.W., B.P.C.v.d.W., M.A.A.P.W.), and Department of Pediatric Neurology (M.A.A.P.W.), Radboud University Medical Center, Nijmegen, the Netherlands; and Complex Motor Disorders Service (J.-P.L.), Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., van de Warrenburg BPC; From the Department of Neurology (R.P.P.W.M.M., T.W., B.P.C.v.d.W.), Donders Institute for Brain, Cognition, and Behaviour (R.P.P.W.M.M., T.W., B.P.C.v.d.W., M.A.A.P.W.), and Department of Pediatric Neurology (M.A.A.P.W.), Radboud University Medical Center, Nijmegen, the Netherlands; and Complex Motor Disorders Service (J.-P.L.), Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Willemsen MAAP; From the Department of Neurology (R.P.P.W.M.M., T.W., B.P.C.v.d.W.), Donders Institute for Brain, Cognition, and Behaviour (R.P.P.W.M.M., T.W., B.P.C.v.d.W., M.A.A.P.W.), and Department of Pediatric Neurology (M.A.A.P.W.), Radboud University Medical Center, Nijmegen, the Netherlands; and Complex Motor Disorders Service (J.-P.L.), Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

المصدر: Neurology [Neurology] 2017 May 09; Vol. 88 (19), pp. 1865-1871. Date of Electronic Publication: 2017 Apr 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Dyskinesia Agents/*administration & dosage , Dystonia/*diagnosis , Dystonia/*drug therapy , Levodopa/*administration & dosage, Anti-Dyskinesia Agents/adverse effects ; Dopamine/biosynthesis ; Dystonia/metabolism ; Humans ; Levodopa/adverse effects